These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 29186401)

  • 1. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
    Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F
    Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.
    Sherazi S; Shah F; Kutyifa V; McNitt S; Aktas MK; Polonsky B; Zareba W; Goldenberg I
    JACC Clin Electrophysiol; 2019 Oct; 5(10):1172-1181. PubMed ID: 31648742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between implantable cardioverter-defibrillator therapy and different lead positions in patients with cardiac resynchronization therapy.
    Kronborg MB; Johansen JB; Haarbo J; Riahi S; Philbert BT; Jørgensen OD; Nielsen JC
    Europace; 2018 Sep; 20(9):e133-e139. PubMed ID: 29036292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QRS Morphology and the Risk of Ventricular Tachyarrhythmia in Cardiac Resynchronization Therapy Recipients.
    Goldenberg I; Aktas MK; Zareba W; Tsu-Chau Huang D; Rosero SZ; Younis A; McNitt S; Stockburger M; Steinberg JS; Buttar RS; Merkely B; Kutyifa V
    JACC Clin Electrophysiol; 2024 Jan; 10(1):16-26. PubMed ID: 38032575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
    Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
    Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.
    Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V
    Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
    Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
    Tilz R; Boveda S; Deharo JC; Dobreanu D; Haugaa KH; Dagres N
    Europace; 2016 Jun; 18(6):945-9. PubMed ID: 27297231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.
    Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyssynchrony and the risk of ventricular arrhythmias.
    Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT.
    Tompkins CM; McNitt S; Polonsky B; Daubert JP; Wang PJ; Moss AJ; Zareba W; Kutyifa V
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):94-102. PubMed ID: 27696593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.
    Medina A; Moss AJ; McNitt S; Zareba W; Wang PJ; Goldenberg I
    Heart Rhythm; 2016 Apr; 13(4):852-9. PubMed ID: 26724489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac device therapy in patients with left ventricular dysfunction and heart failure: 'real-world' data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital).
    Boriani G; Berti E; Belotti LM; Biffi M; De Palma R; Malavasi VL; Bottoni N; Rossi L; De Maria E; Mantovan R; Zardini M; Casali E; Marconi M; Bandini A; Tomasi C; Boggian G; Barbato G; Toselli T; Zennaro M; Sassone B;
    Eur J Heart Fail; 2016 Jun; 18(6):693-702. PubMed ID: 27060289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.